Angiodynamics (ANGO) Equity Ratio (2016 - 2026)
Angiodynamics' Equity Ratio history spans 16 years, with the latest figure at 0.67 for Q1 2026.
- For Q1 2026, Equity Ratio rose 2.12% year-over-year to 0.67; the TTM value through Feb 2026 reached 0.67, up 2.12%, while the annual FY2025 figure was 0.65, 0.92% up from the prior year.
- Equity Ratio reached 0.67 in Q1 2026 per ANGO's latest filing, up from 0.65 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.87 in Q3 2023 to a low of 0.64 in Q4 2024.
- Average Equity Ratio over 5 years is 0.71, with a median of 0.67 recorded in 2025.
- Peak YoY movement for Equity Ratio: grew 16.66% in 2023, then fell 22.71% in 2024.
- A 5-year view of Equity Ratio shows it stood at 0.73 in 2022, then increased by 9.88% to 0.8 in 2023, then fell by 20.23% to 0.64 in 2024, then rose by 2.07% to 0.65 in 2025, then increased by 1.71% to 0.67 in 2026.
- Per Business Quant, the three most recent readings for ANGO's Equity Ratio are 0.67 (Q1 2026), 0.65 (Q4 2025), and 0.67 (Q3 2025).